ArticleFrontiers in pharmacology2024

The combination use of inclisiran and statins versus statins alone in the treatment of dyslipidemia in mainland China: a cost-effectiveness analysis.

Wenjing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.